KCNB2 encodes the voltage-gated potassium channel subunit Kv2.2, a delayed-rectifier channel that helps terminate action potentials and stabilize repetitive firing in excitatory neurons.[1] Kv2.2 is a close paralog of Kv2.1 (KCNB1), but it has distinct localization and biophysical behavior in several neuronal populations, including cortical and hippocampal circuits.[1:1][2] In NeuroWiki terms, KCNB2 sits in the membrane excitability layer of the gene -> protein -> pathway -> phenotype chain.
KCNB2 is located on chromosome 8 and produces transcripts encoding the alpha subunit of Kv2.2.[3] Like other Kv channels, Kv2.2 has six transmembrane segments per subunit and assembles as a tetrameric pore-forming complex.[1:2] Functional channels can include accessory proteins and can coexist with related delayed-rectifier channels that shape spike width and interspike interval.[1:3][2:1]
Key points:
Direct KCNB2-specific neurodegeneration literature is still limited compared with KCNB1 and sodium-channel genes. The strongest current framing is mechanistic rather than disease-specific: altered delayed-rectifier function can shift excitability, calcium load, and metabolic demand, all of which are recurrent stress amplifiers in vulnerable neurons.[1:7][2:4]
This matters in diseases where network hyperexcitability, synaptic failure, or calcium dysregulation are present, including Alzheimer's disease and Parkinson's disease. In those contexts, KCNB2 should be viewed as a candidate modifier node in excitability pathways rather than as a confirmed primary driver.[1:8][2:5]
Recent reports have expanded KCNB2 clinical genetics beyond earlier sparse annotation:
These findings are important for NeuroWiki curation because they provide stronger human evidence for neuronal relevance, even if neurodegenerative causality in late-life disorders remains unproven.
For current translational work, the most practical role for KCNB2 is in panel-level interpretation:
Evidence level should remain conservative for neurodegeneration-specific treatment claims.
Bocksteins E, et al. The subfamily-specific interaction between Kv2.1 and Kv6.4 subunits is determined by interactions between the N- and C-termini. Journal of Biological Chemistry. 2009. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Hille B. Ion Channels of Excitable Membranes. 2001. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
NCBI Gene. KCNB2 potassium voltage-gated channel subfamily B member 2. ↩︎
Galfo M, et al. KCNB2 as an underrecognized neurodevelopmental disease gene in epilepsy and developmental delay. Neurology Genetics. 2024. ↩︎ ↩︎